MedTrace Logo

Effect of Antenatal Corticosteroids on Neonatal Morbidity.

NCT03446937 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-12-27

No results posted yet for this study

Summary

It will be a randomized controlled trial. There will be two study groups. Study group 1 will be given dexamethasone while study group 2 will be given betamethasone. The control group will be given placebo.

Conditions

  • Neonatal Respiratory Distress Syndrome

Interventions

DRUG

Dexamethasone Sodium Phosphate Injection

Dexamethasone sodium phosphate injection 12 mg X doses to be given 12 hours apart

DRUG

Betamethasone Sodium Phosphate Injection (Medication)

betamethasone sodium phosphate injection12mg X 2 doses given 12 hours apart

DRUG

Water for injection

Two doses of intramuscular injection of water for injection given 12 hours apart

Sponsors & Collaborators

  • Ahmadu Bello University Teaching Hospital

    lead OTHER

Principal Investigators

  • Anisah Yahya, MBBS · Ahmadu Bello University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03446937 on ClinicalTrials.gov